Dr Anton Enright read Natural Sciences at Trinity College Dublin, specialising in Genetics before coming to the University of Cambridge for his Ph.D. studies in 1998, with  Prof. Christos Ouzounis, working on protein families and biological network analysis. His postdoctoral work was with Prof. Chris Sander at Memorial Sloan-Kettering Cancer Center, New York working on small RNA target prediction. In 2004 he started his own independent laboratory at the Wellcome Trust Sanger Institute, exploring the functions of small non-coding RNAs in various biological processes and diseases. In 2004 he moved to the EMBL - European Bioinformatics Institute, as a Group Leader where he continued to work on non-coding RNAs, including piwi-associated RNAs, lncRNAs and RNA modifications. His laboratory moved to the Department of Pathology in 2018. Anton is also academic lead for the genomics facility at the department which specialises in large-scale sequencing, microarrays and genotyping projects.

‍